Biogen Valuation
| BIIB34 Stock | BRL 150.16 2.24 1.47% |
At this time, the firm appears to be overvalued. Biogen Inc shows a prevailing Real Value of R$121.63 per share. The current price of the firm is R$150.16. Our model approximates the value of Biogen Inc from analyzing the firm fundamentals such as Current Valuation of 230.79 B, return on equity of 0.2, and Profit Margin of 0.28 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Biogen's price fluctuation is very steady at this time. Calculation of the real value of Biogen Inc is based on 3 months time horizon. Increasing Biogen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Biogen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biogen Stock. However, Biogen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 150.16 | Real 121.63 | Hype 150.16 |
The real value of Biogen Stock, also known as its intrinsic value, is the underlying worth of Biogen Inc Company, which is reflected in its stock price. It is based on Biogen's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Biogen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Biogen Inc helps investors to forecast how Biogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biogen more accurately as focusing exclusively on Biogen's fundamentals will not take into account other important factors: Biogen Total Value Analysis
Biogen Inc is currently forecasted to have takeover price of 230.79 B with market capitalization of 218.2 B, debt of 6.27 B, and cash on hands of 3.91 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Biogen fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
230.79 B | 218.2 B | 6.27 B | 3.91 B |
Biogen Investor Information
The book value of the company was currently reported as 14.82. The company recorded earning per share (EPS) of 16.9. Biogen Inc had not issued any dividends in recent years. Based on the analysis of Biogen's profitability, liquidity, and operating efficiency, Biogen Inc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Biogen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Biogen has an asset utilization ratio of 45.99 percent. This suggests that the Company is making R$0.46 for each dollar of assets. An increasing asset utilization means that Biogen Inc is more efficient with each dollar of assets it utilizes for everyday operations.Biogen Profitability Analysis
The company reported the revenue of 10.98 B. Net Income was 1.56 B with profit before overhead, payroll, taxes, and interest of 8.87 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Biogen's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Biogen and how it compares across the competition.
About Biogen Valuation
The stock valuation mechanism determines Biogen's current worth on a weekly basis. Our valuation model uses a comparative analysis of Biogen. We calculate exposure to Biogen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biogen's related companies.Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts. Biogen operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 7800 people.
8 Steps to conduct Biogen's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Biogen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Biogen's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Biogen's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Biogen's revenue streams: Identify Biogen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Biogen's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Biogen's growth potential: Evaluate Biogen's management, business model, and growth potential.
- Determine Biogen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Biogen's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |